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Multiple myeloma (MM) is a malignancy of plasma cells; these cells accumulate in bone marrow and overproduce a monoclonal protein. The bone disease 
develops in 80%–90% of patients with myeloma and includes 
bone pain, pathologic fractures (PFs) (40%), spinal cord 
compression (5%), and hypercalcemia. These skeletal-related 
events compromise mobility and independence, adversely 
affect the quality of life and are associated with decreased 
survival. Other major clinical manifestations of MM are anemia, 
hypercalcemia, renal failure, and an increased risk of infections 
[1-3]. MM is highly treatable malignancy mainly presents in 
the axial skeleton. Unlike other malignancies that metastasize 
to bone, the osteolytic bone lesions in MM exhibit no new 
bone formation [4]. PFs can occur in extremities, but bilateral 
involvement is extremely rare [5].
We present a case of unusual, spontaneous bilateral humerus 
shaft fractures in a MM patient, managed surgically and followed 
up to 1 year. No similar case was found on the literature search.
CASE REPORT
A 65-year-old man presented to the department of orthopaedic 
with a chief complaint of spontaneous-onset pain in the right arm 
and inability to use the same upper limbs for 3 days. The patient 
also complained of back pain for 3–4 months. There was no 
history of trivial or other traumas and pain in the left arm. He was 
on regular medication for hypertension and chronic obstructive 
pulmonary disease. Informed consent was obtained from the 
patient for taking the photographs. On examination, the patient 
had severe pallor; the midarm region was swollen and tender. 
Tenderness was also noted in the spine and pelvic bones. Other 
systemic examinations were unremarkable.
Radiograph of arm revealed ill-defined osteolytic lesions 
in the acromion, clavicle, scapulae, and shaft and proximal 
humerus bone with fractures (Fig. 1). A chest radiograph showed 
multiple ill-defined osteolytic lesions in multiple ribs, with 
fibrocalcific haze in the right upper and middle zone (Fig. 2). 
A differential diagnosis of metastasis or MM was considered on 
initial screening. The upper limb was splinted. A further skeletal 
survey of skull, spine, and pelvis revealed lytic areas in the skull, 
proximal femur, pelvis, and spine, with a collapse of the 8th and 
12th thoracic vertebra (Figs. 3 and 4). After 5 days of admission, 
while on workup, the patient complained mild pain in the left arm 
and inability to use the same upper limb. There was no history of 
trivial or any other traumas X-ray showed ill-defined osteolytic 
lesions in the shaft and proximal humerus with fracture (Fig. 5), 
the left upper limb was also splinted.
Laboratory tests showed hemoglobin 75 g/L, total leukocyte 
count 5.7×109/L (79% granulocytes, 18% lymphocytes, 1% 
monocytes, and 2% eosinophils), erythrocyte sedimentation rate 
54 mm/1st  h,  C-reactive  protein  12.8  mg/L,  β2  microglobulin 
64.23 mg/L, serum urea 29.4 mmol/L, serum creatinine 1.0 mg%, 
serum calcium 9.2 mg%/dl and serum alkaline phosphatase 
142 U/L, total protein 12.20 g/dl (normal 6.40–8.10 g/dl), serum 
albumin 3.55 g/dl (normal 3.50–5.64 g/dl), and serum globulin 
6.60 g/dl (normal 0.62–1.53 g/dl). Serum protein electrophoresis 
revealed an M band pattern. Urinalysis was negative for Bence 
Jones proteins. Ultrasound whole abdomen revealed bilateral 
basal pleural effusion with a trace of ascites in hepatorenal angle. 
Contrast-enhanced computed tomography chest and abdomen 
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showed osteolytic lesions with a cortical break in most of the 
visualized bones with compression fracture DV8, DV12, and LV2 
bodies. Workup for the primary was negative. Examination of a 
bone marrow aspirate showed moderately increased hypercellular 
marrow with increased plasma cells. A diagnosis of Stage IIIB 
myeloma was made according to the international staging system. 
The patient was given 5 units of whole blood to improve the 
hemoglobin level.
A surgical procedure was performed under scalene block 
anesthesia. In beach-chair position, a deltoid-splitting incision 
was used at the anterior aspect of the acromioclavicular joint 
and was extended about 2.5 cm. The site of entry for the nail into 
the humerus was in the sulcus between the greater tuberosity 
and the articular surface of the humeral head, directly in line 
with the medullary canal. Then, the supraspinatus tendon 
was sharply incised parallel to its fibers to expose the entry 
site. The proximal entry site was perforated, and guidewire 
was passed down into the canal. The appropriate size nail 
was driven with small rotary movements over the guidewire 
without reaming the medullary canal. Proximal interlocking 
was performed with the assistance of a nail-mounted drill 
guide. Two interlocking screws were used to enhance the 
stability of the fixation. Distal interlocking was performed by 
the free-hand technique by carrying out a limited dissection 
through a 5-cm incision to protect the radial nerve. After 
through wash, wound was closed with skin staples. Same 
technique was followed for the left humerus fracture. Post-
operative period was uneventful.
The patient was referred to an oncology center for 
chemotherapy after 1 week when he was stabilized and able to 
use his arms during daily activities with advice of gentle range 
of motion of both shoulder and elbow joint. Lesions at other sites 
including spine and proximal femur were managed conservatively. 
A chemotherapy regimen of thalidomide and dexamethasone 
was started. The patient was followed up for 3 months in the 
outpatient department up to 1 year. At final follow-up, laboratory 
parameters were measured as C-reactive protein 18.0 mg/L, β2 
microglobulin 65.19 mg/L, and serum albumin 3.2 g/dl. There was 
no limitation of range of motion at the elbow joint. The abduction 
of the right and left shoulder was 0–80° and 0–110°, respectively. 
The forward flexion of the right and left shoulder was 0–90° and 
0–120°, respectively. An inappropriate length of nail left outside 
at the proximal entry site was responsible for limited abduction 
Figure 2: Multiple ill-defined osteolytic lesions in multiple ribs, with 
fibrocalcific haze in the right upper and middle zone
Figure 1: Ill-defined osteolytic lesions in acromion, clavicle, scapulae, 
shaft, and proximal humerus with fracture
Figure 4: Lytic lesions in the pelvis and proximal femur
Figure 3: Lytic areas in the spine with collapse of the 8th and 12th 
thoracic vertebra
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in the right shoulder. Humerus fracture showed satisfactory union 
on both sides (Figs. 6 and 7).
DISCUSSION
MM is the second most common hematologic malignancy 
(13%) and accounts for 1% of all cancers. The diagnosis of MM 
is incidental in 30% of cases [6]. PFs have been associated with 
23–32% increased risk of mortality in prostate cancer, breast 
cancer, and MM [7]. The diagnosis of MM requires ≥10% clonal 
bone marrow plasma cells or a biopsy-proven plasmacytoma plus 
evidence of one or more MM defining events consists of CRAB 
(hypercalcemia, renal failure, anemia, or lytic bone lesions) 
features felt related to the plasma cell disorder, bone marrow 
clonal plasmacytosis ≥60%, serum involved/uninvolved free light 
chain  (FLC)  ratio ≥100  (provided  involved FLC  is ≥100 mg/L), 
or >1 focal lesion on magnetic resonance imaging [8]. Bilateral 
spontaneous fracture is extremely rare. Only three cases have been 
reported so far on literature search Table 1 [6,9,10]. Similarly, 
bilateral spontaneous fracture of shaft humerus in MM patient was 
unusual in our report. In the recently published meta-analysis, it 
was concluded that PFs correlate with reduced survival in patients 
with malignant bone disease [11] supported by other similar 
studies. Our initial workup was in favor of metastasis with primary 
in lungs. In our case, chest radiograph showed fibrocalcific haze, 
normal range laboratory parameters, and urinalysis was negative 
for Bence Jones proteins. However, diagnostic certainty came 
from serum electrophoresis, bone marrow examination. Collins 
found Bence Jones proteins in about 49% of cases [12]. In 83% 
of MM cases, serum electrophoresis produces a single band called 
a monoclonal spike or M band [13]. We have managed our case 
with internal fixation with close unreamed interlocking nailing 
on both sides. The closed interlocking humeral nailing is a simple 
and quick procedure and is associated with minimal morbidity and 
low failure in PFs [14]. In similar published studies, there is a lack 
of internal fixation as a management of PFs associated with MM. 
MM has shown improved long-term survival rates due to recent 
advances in treatment options. Survival with conventional therapy 
ranges from 1 to 10 years. The chemotherapy regimens generally 
used are melphalan and prednisone or vincristine, doxorubicin and 
dexamethasone [15]. Autologous stem cell therapy achieves higher 
remission  in  young  patients  with  low  β2  microglobulin  levels. 
Bisphosphonates are also useful in cases of hypercalcemia and 
for the prevention of skeletal-related events [13]. We did not use 
bisphosphates and stem cell therapy in our case as calcium level was 
in normal range. The presented case showed favorable bony union 
Table 1: Review of literature
Study Age & Gender Treatment Chemotherapy  Follow up & Result
Alexa et al6 70, Male Conservative Not mentioned Not mentioned
V Gupta et al9 52, Male Conservative Not mentioned Not mentioned
Singh et al10 49, Male Conservative Vincristine, doxorubicin dexamethasone bis 1 week, died due to severe 
pulmonary infection
Present study 65, Male Close  Interlocking nailing Thalidomide dexamethasone 1 year
Figure 6: Bony union at 1 year with internal fixation in situ right
Figure 5: Ill-defined osteolytic lesions in acromion, clavicle, scapulae, 
shaft, and proximal humerus with fracture
Figure 7: Bony union at 1 year with internal fixation in situ left
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at 1-year follow-up. In similar studies, they are not mentioning 
about follow-up. Gainor and Buchert [16] reported a union rate 
of 67% of fractures in PFs associated with MM. However, further 
studies are needed to determine healing of PFs in such cases.
CONCLUSION
Pathological fractures of long bones associated with MM can be 
satisfactorily treated with internal fixation with adequate adjuvant 
therapy.
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